- ADVERTISEMENT
-
Most Popular
- ADVERTISEMENT
MYL
Valeant Pharmaceuticals Intl Inc (VRX) Is What’s Wrong With America
Valeant Pharmaceuticals have made bad choices that have punished VRX stock holders. But those investors are hardly alone anymore.
Mylan NV (MYL) Stock Holders Can Shrug Off Kaleo’s EpiPen Threat
MYL isn't in trouble after Kaleo's announcement because Mylan stock has already accounted for the damage done by lower EpiPen sales.
Auvi-Q: Inexpensive EpiPen Rival Coming in 2017
Kaleo Pharmaceuticals is releasing the Auvi-Q once again, which is a cheaper alternative to the EpiPen, which has become quite expensive.
7 Pharmaceuticals Stocks to Sell Now
This week, 7 Pharmaceuticals stocks are worse, according to the Portfolio Graderdatabase. Each of these rates a "D" ("sell") or "F" overall ("strong sell").
The Mylan NV (MYL) Stock Relief Rally Won’t Last Long
MYL stock is currently priced high on hopes that it can limit damage over the EpiPen and return to normal. But is this hope enough for Mylan?
3 Big Stock Charts: Mylan NV (MYL), Tyson Foods, Inc. (TSN) and United States Oil Fund LP (ETF) (USO)
The recent move in Mylan (MYL) is likely short-term. In contrast, technical recoveries in Tyson (TSN) and United States Oil Fund (USO) appear to offer more upside potential for technical traders.
Why Alphabet Inc (GOOG), Mylan NV (MYL) And Tesaro Inc (TSRO) Are 3 of Today’s Best Stocks
On a strong day for U.S. equities, GOOG, MYL and TSRO were three of Monday's stud performers.
Biggest Movers in Manufacturing Stocks Now – MCUR IPCI TSRO AEHR
The following stocks were the biggest movers and shakers in the Manufacturing sector today.
3 Stocks to Watch Monday: Mylan NV (MYL), Bristol-Myers Squibb Co (BMY) and Comcast Corporation (CMCSA)
Mylan (MYL) is bouncing back to life on an Epipen settlement, Bristol-Myers Squibb (BMY) is getting hit again on Opdivo disappointment and everyone still hates Comcast (CMCSA).
Why Mylan NV (MYL), Tesla Motors Inc (TSLA) and Twitter Inc (TWTR) Are 3 of Today’s Worst Stocks
Mylan (MYL), Tesla Motors (TSLA) and Twitter (TWTR) shareholders couldn't get rid of their positions fast enough on Thursday.
Hillary Clinton Vs. Donald Trump: Who Will Be Better for Markets?
Markets are rooting for Hillary Clinton, despite the fact that Donald Trump’s policies are probably better for big business.
Stocks Slump Amid Deutsche Bank Fears
In the end, the Dow Jones lost 1.1%, the S&P 500 lost 0.9%, the Nasdaq lost 0.9% and the Russell 2000 lost 1.4%.
Mylan NV (MYL) Scandal Taking Down the Generic Drug Sector
Mylan’s is an easy scandal to understand, and it has delivered an easy villain, making MYL stock an uncomfortable place for investors.
3 Stocks to Watch Tuesday: Kite Pharma Inc (KITE), Array Biopharma Inc (ARRY) and Mylan NV (MYL)
Kite Pharma (KITE) has promising results from its cancer drug's trial, Array Biopharma (ARRY) still is cruising on Monday's news and Mylan (MYL) won't let its scandal die.
How Can an Ethical Investor Stay in This Market? (HPQ)
HP Inc (HPQ) created a monopoly with a software update that makes customers buy its cartridges. It's just one of several ethics issues that investors have to hold their noses near.
UnitedHealth Group Inc (UNH) May Fall Victim to EpiPen Outrage
Mylan may be putting the blame on pharmacy benefit managers for EpiPen's price increase, and UnitedHealth (UNH) is among the biggest.
